| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 19 May 2024 | 12 May 2024 |
| Rainbow Childrens Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2024 inter alia to consider and approve the Audited (Standalone & Consolidated) Financial Results for the period ended March 31 2024 and to consider recommending Final Dividend if any. Recommendation of Final dividend of Rs. 3 per Equity Share for the Financial Year ended March 31, 2024 (As Per BSE Announcement Dated on 19.05.2024) | ||
| Board Meeting | 24 Jan 2024 | 16 Jan 2024 |
| Rainbow Childrens Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 inter alia to consider and approve the Un-Audited (Standalone & Consolidated) Financial results of the Company for the quarter and nine months ended December 31 2023. Un-Audited Financial Results for the Quarter and Nine Months ended December 31, 2023 Appointment of Dr. Adarsh Kancharla as Non-Executive & Non-Independent Director of the Company Un-Audited Financial Results for the quarter and nine months ended December 31, 2023 (As per BSE Announcement Dated on 24/01/2024) | ||
| Board Meeting | 30 Oct 2023 | 20 Oct 2023 |
| Rainbow Childrens Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2023 inter alia to consider and approve the Un-Audited (Standalone & Consolidated) Financial results of the Company for the Quarter and Half Year ended September 30 2023. Un-Audited Financial Results for the Quarter and Half Year ended September 30, 2023 Un-Audited Financial Results for the quarter and half year ended September 30, 2023 Re-appointment of Mr. Aluri Srinivasa Rao as an Independent Director of the Company (As Per BSE Announcement Dated on 30.10.2023) | ||
| Board Meeting | 7 Aug 2023 | 31 Jul 2023 |
| Rainbow Childrens Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 ,inter alia, to consider and approve Meeting of the Board of Directors is scheduled to be held on Monday, August 7, 2023 to inter-alia consider and approve the unaudited (Standalone & Consolidated) Financial results of the Company for the Quarter ended June 30, 2023. Please take note that the Board of Directors of the Company in their meeting held today i.e. August 7, 2023, approved un-Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter ended June 30, 2023. A copy of the signed Results along with Limited Review Reports issued by the Statutory Auditors M/s. S. R. Batliboi & Associates LLP, Chartered Accountants, are attached herewith. Un-Audited Financial Results for the quarter ended June 30, 2023 Outcome of Board Meeting held on August 7, 2023 - Grant of Stock Units (As Per BSE Announcement Dated on 07.08.2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
